One of a Kind

How Innovative Farmers are Tailoring Their Crop Protection

LEARN MORE
Man stands in front of a tractor with lines resembling a thumbprint over him
News from Bayer
December 17, 2024
Not intended for U.S. and UK Media
Aflibercept 8 mg met primary endpoint in phase III study and demonstrates vision gains with extended treatment intervals in retinal vein occlusion
December 13, 2024
Not intended for U.S. and UK Media
Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy
November 12, 2024
Third quarter of 2024
Bayer: Strategic progress in challenging business environment – Group outlook confirmed in nearly all parameters